UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
__________________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 14, 2007
__________________________________
BIOVERIS CORPORATION
(Exact name of Registrant as specified in its charter)
|
Delaware |
000-50583 |
80-0076765 |
|
(State or Other Jurisdiction |
(Commission File Number) |
(I.R.S. Employer |
|
Of Incorporation) |
Identification Number) |
|
16020 Industrial Drive |
|
Gaithersburg, MD 20877 |
(Address of Principal Executive Offices and Zip Code)
_____________________________
(301) 869-9800
(Registrants Telephone Number, Including Area Code)
_____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry Into a Material Definitive Agreement.
On May 14, 2007, the Executive Compensation Committee of the Board of Directors of BioVeris Corporation (the Company) approved cash bonuses to Samuel J. Wohlstadter, the Companys Chairman and Chief Executive Officer, and George Migausky, the Companys Vice President of Finance, Chief Financial Officer and Secretary, of $900,000 and $385,000, respectively, based on each executive officers performance during the Companys fiscal year ended March 31, 2007. Each of the cash awards is payable on or about May 31, 2007. There were no changes in Mr. Wohlstadters and Mr. Migauskys annual base salaries.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 18, 2007 |
BIOVERIS CORPORATION
By:/s/ George V. Migausky Name: George V. Migausky Title: Vice President of Finance and Chief Financial Officer
|
|
|